Renaissance Technologies
EDVA

Renaissance Technologies’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Renaissance Technologies’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,209
Closed -$31.2K – 3786
2024
Q4 		$31.2K Buy
1,209
+193
+19% +$6.4K ﹤0.01% 3450
2024
Q3 		$41K Buy
1,016
+417
+70% +$21K ﹤0.01% 3367
2024
Q2 		$22.1K Buy
599
+263
+78% +$12.3K ﹤0.01% 3374
2024
Q1 		$25K Buy
336
+101
+43% +$8.05K ﹤0.01% 3571
2023
Q4 		$21K Buy
235
+53
+29% +$5.05K ﹤0.01% 3575
2023
Q3 		$17K Sell
182
-121
-40% -$15.7K ﹤0.01% 3539
2023
Q2 		$54K Buy
+303
New +$55.4K ﹤0.01% 3602

Other funds holding EDVA

CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies's EDVA Position: Q1 2025 in Review

Renaissance Technologies sold out of Endovia Health Sciences, Inc. (EDVA) in Q1 2025, closing a stake of 1,209 shares — an estimated $31.2K sold.

Renaissance Technologies first reported a position in EDVA in Q2 2023 and held it in 7 quarters. The position peaked at $54K in Q2 2023. 11 funds tracked by Wall St. Rank hold EDVA as of Q1 2025.

  • Renaissance Technologies reported no remaining Endovia Health Sciences, Inc. position as of Q1 2025 after selling out during the quarter.
  • Renaissance Technologies sold 1,209 Endovia Health Sciences, Inc. shares in Q1 2025, an estimated $31.2K.
  • Renaissance Technologies first reported a position in Endovia Health Sciences, Inc. in Q2 2023 and held it in 7 quarters.
  • Renaissance Technologies's Endovia Health Sciences, Inc. position peaked at $54K in Q2 2023.
  • 11 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q1 2025.

Based on Renaissance Technologies's 13F filing for Q1 2025, filed 14 May 2025.